Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 168 entries
Sorted by: Best Match Show Resources per page
Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma.

Journal of hepatology

Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, Amato G, Mennini G, Franchitto M, Conti F, Rossi M, Riminucci M, Gaudio E, Alvaro D, Mancone C.
PMID: 34329660
J Hepatol. 2021 Dec;75(6):1377-1386. doi: 10.1016/j.jhep.2021.07.016. Epub 2021 Jul 28.

BACKGROUND & AIMS: The microenvironment of intrahepatic cholangiocarcinoma (iCCA) is hypovascularized, with an extensive lymphatic network. This leads to rapid cancer spread into regional lymph nodes and the liver parenchyma, precluding curative treatments. Herein, we investigated which factors released...

Cite
Carpino G, Cardinale V, Di Giamberardino A, et al. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol. 2021;75(6):1377-1386doi: 10.1016/j.jhep.2021.07.016.
Carpino, G., Cardinale, V., Di Giamberardino, A., Overi, D., Donsante, S., Colasanti, T., Amato, G., Mennini, G., Franchitto, M., Conti, F., Rossi, M., Riminucci, M., Gaudio, E., Alvaro, D., & Mancone, C. (2021). Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. Journal of hepatology, 75(6), 1377-1386. https://doi.org/10.1016/j.jhep.2021.07.016
Carpino, Guido, et al. "Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma." Journal of hepatology vol. 75,6 (2021): 1377-1386. doi: https://doi.org/10.1016/j.jhep.2021.07.016
Carpino G, Cardinale V, Di Giamberardino A, Overi D, Donsante S, Colasanti T, Amato G, Mennini G, Franchitto M, Conti F, Rossi M, Riminucci M, Gaudio E, Alvaro D, Mancone C. Thrombospondin 1 and 2 along with PEDF inhibit angiogenesis and promote lymphangiogenesis in intrahepatic cholangiocarcinoma. J Hepatol. 2021 Dec;75(6):1377-1386. doi: 10.1016/j.jhep.2021.07.016. Epub 2021 Jul 28. PMID: 34329660.
Copy Download .nbib Format: NLM
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement.

European heart journal

Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P.
PMID: 34904661
Eur Heart J. 2021 Dec 14; doi: 10.1093/eurheartj/ehab674. Epub 2021 Dec 14.

The discipline of Cardio-Oncology has seen tremendous growth over the past decade. It is devoted to the cardiovascular (CV) care of the cancer patient, especially to the mitigation and management of CV complications or toxicities of cancer therapies, which...

Cite
Herrmann J, Lenihan D, Armenian S, et al. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2021;doi: 10.1093/eurheartj/ehab674.
Herrmann, J., Lenihan, D., Armenian, S., Barac, A., Blaes, A., Cardinale, D., Carver, J., Dent, S., Ky, B., Lyon, A. R., López-Fernández, T., Fradley, M. G., Ganatra, S., Curigliano, G., Mitchell, J. D., Minotti, G., Lang, N. N., Liu, J. E., Neilan, T. G., Nohria, A., O'Quinn, R., Pusic, I., Porter, C., Reynolds, K. L., Ruddy, K. J., Thavendiranathan, P., & Valent, P. (2021). Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. European heart journal, . https://doi.org/10.1093/eurheartj/ehab674
Herrmann, Joerg, et al. "Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement." European heart journal vol. (2021). doi: https://doi.org/10.1093/eurheartj/ehab674
Herrmann J, Lenihan D, Armenian S, Barac A, Blaes A, Cardinale D, Carver J, Dent S, Ky B, Lyon AR, López-Fernández T, Fradley MG, Ganatra S, Curigliano G, Mitchell JD, Minotti G, Lang NN, Liu JE, Neilan TG, Nohria A, O'Quinn R, Pusic I, Porter C, Reynolds KL, Ruddy KJ, Thavendiranathan P, Valent P. Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement. Eur Heart J. 2021 Dec 14; doi: 10.1093/eurheartj/ehab674. Epub 2021 Dec 14. PMID: 34904661.
Copy Download .nbib Format: NLM
Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases.

Journal for immunotherapy of cancer

Minniti G, Lanzetta G, Capone L, Giraffa M, Russo I, Cicone F, Bozzao A, Alongi F, Nicosia L, Fineschi G, Marchetti L, Tufo T, Bianciardi F, Esposito V, Gentile P, Paolini S.
PMID: 34949695
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003730.

PURPOSE: Immunotherapy has shown activity in patients with brain metastases (BM) and leptomeningeal disease (LMD). We have evaluated LMD and intraparenchymal control rates for patients with resected BM receiving postoperative stereotactic radiosurgery (SRS) and immunotherapy or postoperative SRS alone....

Cite
Minniti G, Lanzetta G, Capone L, et al. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases. J Immunother Cancer. 2021;9(12)doi: 10.1136/jitc-2021-003730.
Minniti, G., Lanzetta, G., Capone, L., Giraffa, M., Russo, I., Cicone, F., Bozzao, A., Alongi, F., Nicosia, L., Fineschi, G., Marchetti, L., Tufo, T., Bianciardi, F., Esposito, V., Gentile, P., & Paolini, S. (2021). Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases. Journal for immunotherapy of cancer, 9(12), . https://doi.org/10.1136/jitc-2021-003730
Minniti, Giuseppe, et al. "Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases." Journal for immunotherapy of cancer vol. 9,12 (2021). doi: https://doi.org/10.1136/jitc-2021-003730
Minniti G, Lanzetta G, Capone L, Giraffa M, Russo I, Cicone F, Bozzao A, Alongi F, Nicosia L, Fineschi G, Marchetti L, Tufo T, Bianciardi F, Esposito V, Gentile P, Paolini S. Leptomeningeal disease and brain control after postoperative stereotactic radiosurgery with or without immunotherapy for resected brain metastases. J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003730. PMID: 34949695; PMCID: PMC8705219.
Copy Download .nbib Format: NLM
Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM).

European radiology

Mazzei MA, Bagnacci G, Gentili F, Capitoni I, Mura G, Marrelli D, Petrioli R, Brunese L, Cappabianca S, Catarci M, Degiuli M, De Manzoni G, De Prizio M, Donini A, Romario UF, Funicelli L, Laghi A, Minetti G, Morgagni P, Petrella E, Pittiani F, Rausei S, Romanini L, Rosati R, Ianora AAS, Tiberio GAM, Volterrani L, Roviello F, Grassi R.
PMID: 34383148
Eur Radiol. 2021 Aug 12; doi: 10.1007/s00330-021-08205-0. Epub 2021 Aug 12.

OBJECTIVES: Written radiological report remains the most important means of communication between radiologist and referring medical/surgical doctor, even though CT reports are frequently just descriptive, unclear, and unstructured. The Italian Society of Medical and Interventional Radiology (SIRM) and the...

Cite
Mazzei MA, Bagnacci G, Gentili F, et al. Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). Eur Radiol. 2021;doi: 10.1007/s00330-021-08205-0.
Mazzei, M. A., Bagnacci, G., Gentili, F., Capitoni, I., Mura, G., Marrelli, D., Petrioli, R., Brunese, L., Cappabianca, S., Catarci, M., Degiuli, M., De Manzoni, G., De Prizio, M., Donini, A., Romario, U. F., Funicelli, L., Laghi, A., Minetti, G., Morgagni, P., Petrella, E., Pittiani, F., Rausei, S., Romanini, L., Rosati, R., Ianora, A. A. S., Tiberio, G. A. M., Volterrani, L., Roviello, F., & Grassi, R. (2021). Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). European radiology, . https://doi.org/10.1007/s00330-021-08205-0
Mazzei, Maria Antonietta, et al. "Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM)." European radiology vol. (2021). doi: https://doi.org/10.1007/s00330-021-08205-0
Mazzei MA, Bagnacci G, Gentili F, Capitoni I, Mura G, Marrelli D, Petrioli R, Brunese L, Cappabianca S, Catarci M, Degiuli M, De Manzoni G, De Prizio M, Donini A, Romario UF, Funicelli L, Laghi A, Minetti G, Morgagni P, Petrella E, Pittiani F, Rausei S, Romanini L, Rosati R, Ianora AAS, Tiberio GAM, Volterrani L, Roviello F, Grassi R. Structured and shared CT radiological report of gastric cancer: a consensus proposal by the Italian Research Group for Gastric Cancer (GIRCG) and the Italian Society of Medical and Interventional Radiology (SIRM). Eur Radiol. 2021 Aug 12; doi: 10.1007/s00330-021-08205-0. Epub 2021 Aug 12. PMID: 34383148; PMCID: PMC8359760.
Copy Download .nbib Format: NLM
Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves.

American journal of blood research

Hollister BM, Zilbermint M, Minniti CP, Buscetta AJ, Abdallah KE, You S, Soldin SJ, Meyer JS, Stratakis CA, Bonham VL.
PMID: 34079627
Am J Blood Res. 2021 Apr 15;11(2):140-148. eCollection 2021.

INTRODUCTION: Sickle cell disease (SCD) is a chronic illness that presents with a wide range of phenotypic variation. Stress may be a contributing factor to differences that are found in this population.OBJECTIVES: Our objective is to determine the relationship...

Cite
Hollister BM, Zilbermint M, Minniti CP, et al. Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves. Am J Blood Res. 2021;11(2):140-148
Hollister, B. M., Zilbermint, M., Minniti, C. P., Buscetta, A. J., Abdallah, K. E., You, S., Soldin, S. J., Meyer, J. S., Stratakis, C. A., & Bonham, V. L. (2021). Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves. American journal of blood research, 11(2), 140-148.
Hollister, Brittany M, et al. "Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves." American journal of blood research vol. 11,2 (2021): 140-148.
Hollister BM, Zilbermint M, Minniti CP, Buscetta AJ, Abdallah KE, You S, Soldin SJ, Meyer JS, Stratakis CA, Bonham VL. Lower hair cortisol among patients with sickle cell disease may indicate decreased adrenal reserves. Am J Blood Res. 2021 Apr 15;11(2):140-148. eCollection 2021. PMID: 34079627; PMCID: PMC8165714.
Copy Download .nbib Format: NLM
Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes.

JACC. CardioOncology

Minotti G, Camilli M.
PMID: 34988483
JACC CardioOncol. 2021 Dec 21;3(5):734-736. doi: 10.1016/j.jaccao.2021.11.004. eCollection 2021 Dec.

No abstract available.

Cite
Minotti G, Camilli M. Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes. JACC CardioOncol. 2021;3(5):734-736doi: 10.1016/j.jaccao.2021.11.004.
Minotti, G., & Camilli, M. (2021). Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes. JACC. CardioOncology, 3(5), 734-736. https://doi.org/10.1016/j.jaccao.2021.11.004
Minotti, Giorgio, and Camilli, Massimiliano. "Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes." JACC. CardioOncology vol. 3,5 (2021): 734-736. doi: https://doi.org/10.1016/j.jaccao.2021.11.004
Minotti G, Camilli M. Risk of Myocardial Infarction in Patients Treated With 5-Fluorouracil: Balancing the Evidence With Black Boxes. JACC CardioOncol. 2021 Dec 21;3(5):734-736. doi: 10.1016/j.jaccao.2021.11.004. eCollection 2021 Dec. PMID: 34988483; PMCID: PMC8702785.
Copy Download .nbib Format: NLM
An Invitation from the Editors of Cardio-Oncology.

Cardio-oncology (London, England)

Lipshultz SE, Minotti G, Carver J, Franco VI.
PMID: 33530142
Cardiooncology. 2015 Nov 26;1(1):2. doi: 10.1186/s40959-015-0004-9.

No abstract available.

Cite
Lipshultz SE, Minotti G, Carver J, et al. An Invitation from the Editors of Cardio-Oncology. Cardiooncology. 2015;1(1):2doi: 10.1186/s40959-015-0004-9.
Lipshultz, S. E., Minotti, G., Carver, J., & Franco, V. I. (2015). An Invitation from the Editors of Cardio-Oncology. Cardio-oncology (London, England), 1(1), 2. https://doi.org/10.1186/s40959-015-0004-9
Lipshultz, Steven E, et al. "An Invitation from the Editors of Cardio-Oncology." Cardio-oncology (London, England) vol. 1,1 (2015): 2. doi: https://doi.org/10.1186/s40959-015-0004-9
Lipshultz SE, Minotti G, Carver J, Franco VI. An Invitation from the Editors of Cardio-Oncology. Cardiooncology. 2015 Nov 26;1(1):2. doi: 10.1186/s40959-015-0004-9. PMID: 33530142; PMCID: PMC7837149.
Copy Download .nbib Format: NLM
Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma.

JAMA surgery

Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, Brar G, Sasaki K, Doyle MBM, Tabrizian P, Agopian VG, Najjar M, Ivanics T, Samstein B, Brown RS, Emond JC, Yao F, Lerut J, Rossi M, Mennini G, Iesari S, Finkenstedt A, Schaefer B, Mittler J, Hoppe-Lotichius M, Quintini C, Aucejo F, Chapman W, Sapisochin G.
PMID: 33950167
JAMA Surg. 2021 Jun 01;156(6):559-567. doi: 10.1001/jamasurg.2021.0954.

IMPORTANCE: Accurate preoperative prediction of hepatocellular carcinoma (HCC) recurrence after liver transplant is the mainstay of selection tools used by transplant-governing bodies to discern candidacy for patients with HCC. Although progress has been made, few tools incorporate objective measures...

Cite
Halazun KJ, Rosenblatt RE, Mehta N, et al. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. JAMA Surg. 2021;156(6):559-567doi: 10.1001/jamasurg.2021.0954.
Halazun, K. J., Rosenblatt, R. E., Mehta, N., Lai, Q., Hajifathalian, K., Gorgen, A., Brar, G., Sasaki, K., Doyle, M. B. M., Tabrizian, P., Agopian, V. G., Najjar, M., Ivanics, T., Samstein, B., Brown, R. S., Emond, J. C., Yao, F., Lerut, J., Rossi, M., Mennini, G., Iesari, S., Finkenstedt, A., Schaefer, B., Mittler, J., Hoppe-Lotichius, M., Quintini, C., Aucejo, F., Chapman, W., & Sapisochin, G. (2021). Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. JAMA surgery, 156(6), 559-567. https://doi.org/10.1001/jamasurg.2021.0954
Halazun, Karim J, et al. "Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma." JAMA surgery vol. 156,6 (2021): 559-567. doi: https://doi.org/10.1001/jamasurg.2021.0954
Halazun KJ, Rosenblatt RE, Mehta N, Lai Q, Hajifathalian K, Gorgen A, Brar G, Sasaki K, Doyle MBM, Tabrizian P, Agopian VG, Najjar M, Ivanics T, Samstein B, Brown RS, Emond JC, Yao F, Lerut J, Rossi M, Mennini G, Iesari S, Finkenstedt A, Schaefer B, Mittler J, Hoppe-Lotichius M, Quintini C, Aucejo F, Chapman W, Sapisochin G. Dynamic α-Fetoprotein Response and Outcomes After Liver Transplant for Hepatocellular Carcinoma. JAMA Surg. 2021 Jun 01;156(6):559-567. doi: 10.1001/jamasurg.2021.0954. PMID: 33950167; PMCID: PMC8100910.
Copy Download .nbib Format: NLM
Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes.

Journal of clinical medicine

Trungu S, Ricciardi L, Forcato S, Scollato A, Minniti G, Miscusi M, Raco A.
PMID: 34945214
J Clin Med. 2021 Dec 16;10(24). doi: 10.3390/jcm10245910.

No abstract available.

Cite
Trungu S, Ricciardi L, Forcato S, et al. Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes. J Clin Med. 2021;10(24)doi: 10.3390/jcm10245910.
Trungu, S., Ricciardi, L., Forcato, S., Scollato, A., Minniti, G., Miscusi, M., & Raco, A. (2021). Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes. Journal of clinical medicine, 10(24), . https://doi.org/10.3390/jcm10245910
Trungu, Sokol, et al. "Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes." Journal of clinical medicine vol. 10,24 (2021). doi: https://doi.org/10.3390/jcm10245910
Trungu S, Ricciardi L, Forcato S, Scollato A, Minniti G, Miscusi M, Raco A. Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes. J Clin Med. 2021 Dec 16;10(24). doi: 10.3390/jcm10245910. PMID: 34945214.
Copy Download .nbib Format: NLM
Voxelotor Use in Adults with Sickle Cell Disease in a Real-World Setting.

American journal of hematology

Curtis SA, Betancourt J, Kottapalli N, Campbell S, Minniti C.
PMID: 34967959
Am J Hematol. 2021 Dec 30; doi: 10.1002/ajh.26453. Epub 2021 Dec 30.

No abstract available.

Cite
Curtis SA, Betancourt J, Kottapalli N, et al. Voxelotor Use in Adults with Sickle Cell Disease in a Real-World Setting. Am J Hematol. 2021;doi: 10.1002/ajh.26453.
Curtis, S. A., Betancourt, J., Kottapalli, N., Campbell, S., & Minniti, C. (2021). Voxelotor Use in Adults with Sickle Cell Disease in a Real-World Setting. American journal of hematology, . https://doi.org/10.1002/ajh.26453
Curtis, Susanna A, et al. "Voxelotor Use in Adults with Sickle Cell Disease in a Real-World Setting." American journal of hematology vol. (2021). doi: https://doi.org/10.1002/ajh.26453
Curtis SA, Betancourt J, Kottapalli N, Campbell S, Minniti C. Voxelotor Use in Adults with Sickle Cell Disease in a Real-World Setting. Am J Hematol. 2021 Dec 30; doi: 10.1002/ajh.26453. Epub 2021 Dec 30. PMID: 34967959.
Copy Download .nbib Format: NLM
The Humble Charisma of a White-Dressed Man in a Desert Place: Pope Francis' Communicative Style in the Covid-19 Pandemic.

Frontiers in psychology

Scardigno R, Papapicco C, Luccarelli V, Zagaria AE, Mininni G, D'Errico F.
PMID: 34539488
Front Psychol. 2021 Sep 01;12:683259. doi: 10.3389/fpsyg.2021.683259. eCollection 2021.

The context of deep uncertainty, fear, and "social distancing" characterizing the COVID-19 pandemic has led to a need for cultural anchorages and charismatic leaders who may conjointly and effectively support human beings, strengthen their identity, and empower social commitment....

Cite
Scardigno R, Papapicco C, Luccarelli V, et al. The Humble Charisma of a White-Dressed Man in a Desert Place: Pope Francis' Communicative Style in the Covid-19 Pandemic. Front Psychol. 2021;12:683259doi: 10.3389/fpsyg.2021.683259.
Scardigno, R., Papapicco, C., Luccarelli, V., Zagaria, A. E., Mininni, G., & D'Errico, F. (2021). The Humble Charisma of a White-Dressed Man in a Desert Place: Pope Francis' Communicative Style in the Covid-19 Pandemic. Frontiers in psychology, 12683259. https://doi.org/10.3389/fpsyg.2021.683259
Scardigno, Rosa, et al. "The Humble Charisma of a White-Dressed Man in a Desert Place: Pope Francis' Communicative Style in the Covid-19 Pandemic." Frontiers in psychology vol. 12 (2021): 683259. doi: https://doi.org/10.3389/fpsyg.2021.683259
Scardigno R, Papapicco C, Luccarelli V, Zagaria AE, Mininni G, D'Errico F. The Humble Charisma of a White-Dressed Man in a Desert Place: Pope Francis' Communicative Style in the Covid-19 Pandemic. Front Psychol. 2021 Sep 01;12:683259. doi: 10.3389/fpsyg.2021.683259. eCollection 2021. PMID: 34539488; PMCID: PMC8440828.
Copy Download .nbib Format: NLM
Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy.

Journal for immunotherapy of cancer

Cortellini A, Di Maio M, Nigro O, Leonetti A, Cortinovis DL, Aerts JG, Guaitoli G, Barbieri F, Giusti R, Ferrara MG, Bria E, D'Argento E, Grossi F, Rijavec E, Guida A, Berardi R, Torniai M, Sforza V, Genova C, Mazzoni F, Garassino MC, De Toma A, Signorelli D, Gelibter A, Siringo M, Marchetti P, Macerelli M, Rastelli F, Chiari R, Rocco D, Della Gravara L, Inno A, Michele T, Grassadonia A, Di Marino P, Mansueto G, Zoratto F, Filetti M, Santini D, Citarella F, Russano M, Cantini L, Tuzi A, Bordi P, Minuti G, Landi L, Ricciardi S, Migliorino MR, Passiglia F, Bironzo P, Metro G, Adamo V, Russo A, Spinelli GP, Banna GL, Friedlaender A, Addeo A, Cannita K, Ficorella C, Porzio G, Pinato DJ.
PMID: 33827906
J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2021-002421.

BACKGROUND: Some concomitant medications including antibiotics (ATB) have been reproducibly associated with worse survival following immune checkpoint inhibitors (ICIs) in unselected patients with non-small cell lung cancer (NSCLC) (according to programmed death-ligand 1 (PD-L1) expression and treatment line). Whether...

Cite
Cortellini A, Di Maio M, Nigro O, et al. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. J Immunother Cancer. 2021;9(4)doi: 10.1136/jitc-2021-002421.
Cortellini, A., Di Maio, M., Nigro, O., Leonetti, A., Cortinovis, D. L., Aerts, J. G., Guaitoli, G., Barbieri, F., Giusti, R., Ferrara, M. G., Bria, E., D'Argento, E., Grossi, F., Rijavec, E., Guida, A., Berardi, R., Torniai, M., Sforza, V., Genova, C., Mazzoni, F., Garassino, M. C., De Toma, A., Signorelli, D., Gelibter, A., Siringo, M., Marchetti, P., Macerelli, M., Rastelli, F., Chiari, R., Rocco, D., Della Gravara, L., Inno, A., Michele, T., Grassadonia, A., Di Marino, P., Mansueto, G., Zoratto, F., Filetti, M., Santini, D., Citarella, F., Russano, M., Cantini, L., Tuzi, A., Bordi, P., Minuti, G., Landi, L., Ricciardi, S., Migliorino, M. R., Passiglia, F., Bironzo, P., Metro, G., Adamo, V., Russo, A., Spinelli, G. P., Banna, G. L., Friedlaender, A., Addeo, A., Cannita, K., Ficorella, C., Porzio, G., & Pinato, D. J. (2021). Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. Journal for immunotherapy of cancer, 9(4), . https://doi.org/10.1136/jitc-2021-002421
Cortellini, Alessio, et al. "Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy." Journal for immunotherapy of cancer vol. 9,4 (2021). doi: https://doi.org/10.1136/jitc-2021-002421
Cortellini A, Di Maio M, Nigro O, Leonetti A, Cortinovis DL, Aerts JG, Guaitoli G, Barbieri F, Giusti R, Ferrara MG, Bria E, D'Argento E, Grossi F, Rijavec E, Guida A, Berardi R, Torniai M, Sforza V, Genova C, Mazzoni F, Garassino MC, De Toma A, Signorelli D, Gelibter A, Siringo M, Marchetti P, Macerelli M, Rastelli F, Chiari R, Rocco D, Della Gravara L, Inno A, Michele T, Grassadonia A, Di Marino P, Mansueto G, Zoratto F, Filetti M, Santini D, Citarella F, Russano M, Cantini L, Tuzi A, Bordi P, Minuti G, Landi L, Ricciardi S, Migliorino MR, Passiglia F, Bironzo P, Metro G, Adamo V, Russo A, Spinelli GP, Banna GL, Friedlaender A, Addeo A, Cannita K, Ficorella C, Porzio G, Pinato DJ. Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. J Immunother Cancer. 2021 Apr;9(4). doi: 10.1136/jitc-2021-002421. PMID: 33827906; PMCID: PMC8031700.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 168 entries